Neuroleptic malignant syndrome associated with Olanzapine therapy: a case report
β Scribed by Stephen C Stanfield; Troy Privette
- Book ID
- 117561397
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 53 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0736-4679
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We describe here a case of olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome in a 64 yearβold woman with a significant medical history. Eighteen weeks after initiating olanzapine, Mrs X lost glycemic control, exhibited signs and symptoms consistent with
A 30-year-old white man with schizophrenia developed anorexia and nausea, and was admitted to hospital for confusion and delirium. He was on olanzapine, 10 days prior to admission. On admission, typical neuroleptic malignant syndrome (NMS) developed with elevated body temperature (39.7 degrees C), o
## Abstract Neuroleptic malignant syndrome is the rarest and the most serious of the neuroleptic induced movement disorders. Although potent neuroleptics are more frequently associated with NMS, atypical antipsychotic drugs may also be a cause of NMS. Three databases were searched using the terms β